ReviewFrontiers in oncology2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacy.
Muhamed Baljevic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it